ArticlePloS one2014

A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.

Thomas H King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.